PIRS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

Stats
Dzisiejszy wolumen	5 331
Średni wolumen	12 803
Kapitalizacja rynkowa	11.33M
EPS	$-3.95 ( Q1 \| 2024-05-15 )
Następna data zysków	( $-0.120 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.750 (Sector) 42.63 (Industry) 24.32
ATR14	$0.157 (1.83%)

AADI 3.55%

ABCL -3.79%

ABCM 0.04%

ABEO -5.02%

ABIO -0.29%

ABOS -3.03%

ABSI 0.66%

ABUS 0.66%

ABVX 2.61%

ACAD 3.79%

ACER -17.95%

ACET 9.49%

ACGN 1.29%

ACHL 0.22%

ACHV -4.83%

ACIU 2.47%

ACLX -0.09%

ACRV -5.30%

ACST -0.31%

ACXP -2.15%

ADAG 0.69%

ADAP -1.06%

ADGI 0.87%

ADIL 2.68%

ADMA 0.09%

ADPT 1.54%

ADTX -2.08%

ADVM 1.63%

ADXN -5.75%

AEON -7.34%

AEZS -1.10%

AFMD 1.02%

AGEN 4.60%

AGIO 0.02%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -0.69%

AKRO 2.80%

AKTX -1.08%

AKUS 0.00%

ALBO 0.00%

ALDX -5.46%

ALEC 0.44%

ALGS -4.88%

ALKS -1.28%

ALLK 8.11%

ALLO 2.35%

ALLR -28.40%

ALNA 3.16%

ALNY 34.52%

ALPN 0.02%

ALPX 0.00%

ALRN -1.60%

ALT 11.39%

ALVR 4.92%

ALXN 0.00%

ALXO -0.15%

ALZN -7.26%

AMRN 2.72%

AMTI -3.13%

ANAB 0.21%

ANEB -1.49%

ANGN 0.00%

ANIX -0.79%

ANL 0.29%

ANNX -4.22%

ANPC -3.15%

APGE 2.63%

APGN 8.48%

APGNW 30.65%

APLM 9.95%

APLS 0.92%

APLT 1.76%

APM 1.73%

APOP 0.38%

APRE 3.24%

APTO -2.37%

APTX 3.17%

APVO 1.15%

ARAV -13.39%

ARCT -0.44%

ARDS 2.49%

ARDX 1.46%

ARGX 11.69%

ARNA 0.00%

ARPO -0.90%

ARQT 4.59%

ARTL -2.71%

ARTLW 0.00%

ARVN -0.99%

ARWR 6.82%

ASLN -2.99%

ASMB 0.38%

ASND 1.20%

ATAI 4.48%

ATHA 1.28%

ATHE 2.27%

ATHX -33.50%

ATNF 2.05%

ATOS -5.31%

ATRA 0.67%

ATXI 9.52%

ATXS -2.65%

AUPH 2.35%

AURA -1.25%

AUTL -2.87%

AVBP -0.78%

AVEO 0.00%

AVIR 1.45%

AVRO -1.41%

AVTE -3.85%

AVTX 2.99%

AVXL 3.19%

AXLA 0.00%

AXSM 2.76%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -15.94%

BCAB 3.31%

BCDA -5.67%

BCDAW -39.75%

BCEL 0.00%

BCLI 2.70%

BCRX -2.34%

BCTX -7.44%

BCTXW -18.26%

BCYC 0.10%

BDRX -15.63%

BDTX 0.83%

BEAM 8.24%

BFRA -2.91%

BGNE 1.95%

BIOR 1.50%

BIVI 0.96%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX 3.39%

BLTE 0.27%

BLU 0.03%

BLUE 13.45%

BMEA 5.51%

BMRN 1.62%

BNOX 2.99%

BNTC 4.80%

BNTX 2.33%

BOLD 13.42%

BOLT -1.45%

BPMC 1.79%

BPTH 0.88%

BPTS -13.47%

BRNS 0.00%

BRTX 1.72%

BTAI 4.39%

BTTX 0.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -1.78%

CABA -1.53%

CADL 1.82%

CALA 0.00%

CALC -1.87%

CALT 1.83%

CAPR 1.91%

CARA 22.71%

CARM 9.80%

CASI 7.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.40%

CCCC 11.08%

CCXI 0.00%

CDAK 0.00%

CDIO -0.17%

CDIOW 36.86%

CDMO -4.38%

CDMOP 0.04%

CDT -7.05%

CDTTW -23.91%

CDTX -2.84%

CDXC -6.59%

CDXS 2.04%

CELC 4.58%

CELU 0.66%

CELUW 11.18%

CERC -1.68%

CERE -0.55%

CERO 2.09%

CEROW -22.90%

CFRX -27.95%

CGEM -0.34%

CGEN -5.08%

CGON 1.50%

CGTX -2.63%

CHMA -6.00%

CHRS -2.40%

CINC 0.00%

CING 4.73%

CINGW 73.79%

CKPT 15.56%

CLBS -16.75%

CLDX 2.55%

CLGN 6.22%

CLLS 1.06%

CLNN -3.46%

CLNNW -33.25%

CLRB 0.00%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB 8.57%

CMND -7.59%

CMPI 0.00%

CMPX 0.91%

CMRA 0.00%

CMRAW 33.33%

CMRX 1.85%

CNCE 0.00%

CNSP 12.63%

CNST 0.00%

CNTA -2.31%

CNTB -6.25%

CNTX 0.93%

COCP -1.88%

COEPW 0.00%

COGT 1.14%

CORT 1.83%

COYA -2.48%

CPRX -1.28%

CRBP 2.42%

CRBU 8.72%

CRDF -3.67%

CRGX 4.50%

CRIS 3.02%

CRNX 0.18%

CRSP 3.02%

CRTX 2.63%

CRVO 0.40%

CRVS 2.81%

CSBR -1.20%

CTCX -7.84%

CTIC 0.06%

CTMX 3.10%

CTNM 3.23%

CTXR 4.68%

CUE 8.89%

CVAC 6.44%

CVKD 6.24%

CWBR 0.00%

CYAD -12.96%

CYCC -5.01%

CYCCP 4.03%

CYCN 6.69%

CYT -2.27%

CYTK 0.71%

CYTO 2.61%

DARE 1.96%

DAWN -1.10%

DBTX -0.81%

DBVT -1.80%

DFFN 10.28%

DICE 0.06%

DMAC 2.78%

DNLI 1.24%

DNTH -0.04%

DOMH -2.63%

DRMA 12.50%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.62%

DRTSW 0.00%

DRUG -3.77%

DSGN -0.59%

DTIL 0.85%

DYAI -9.66%

EARS -1.77%

EDIT -0.59%

EDSA -0.11%

EFTR -75.81%

EFTRW -96.33%

EIGR -9.21%

ELAB 0.86%

ELDN -4.40%

ELEV -4.30%

ELOX 0.00%

ELTX 6.89%

ELVN 1.87%

ELYM -8.69%

ENGN -9.67%

ENGNW -7.87%

ENLV 3.68%

ENOB 1.79%

ENSC 4.98%

ENTA 2.43%

ENTO -2.13%

ENTX 1.98%

ENVB 9.19%

EPIX -1.02%

EPRX 0.57%

EPZM 0.00%

EQ 2.52%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.37%

ERNA -4.64%

ERYP 1.30%

ESLA -0.50%

ESLAW 0.00%

ETNB -0.82%

ETON -0.60%

ETTX 0.00%

EVAX -5.28%

EVGN -2.18%

EVLO 0.00%

EWTX -1.99%

EXAI -2.78%

EXEL 0.54%

EYEG 0.11%

EYEN 2.28%

EYPT 0.59%

FATE 2.13%

FBIO -3.95%

FBIOP 0.59%

FBLG 5.49%

FBRX 0.27%

FDMT 1.35%

FENC -1.09%

FGEN 6.19%

FHTX 0.38%

FIXX 0.77%

FMTX 0.00%

FNCH -6.77%

FOLD -0.89%

FREQ 4.76%

FRLN 0.15%

FRTX -4.51%

FSTX 0.00%

FTRE -0.65%

FULC -5.09%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -8.97%

GANX 0.00%

GBIO 1.45%

GBT 0.01%

GDTC 5.61%

GERN -1.29%

GHRS 0.42%

GLMD -1.83%

GLPG 1.67%

GLSI -4.73%

GLTO 5.51%

GLUE 4.96%

GLYC 3.61%

GMAB -0.81%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 1.29%

GNLX 10.68%

GNPX 0.00%

GNTA 7.74%

GOSS 27.09%

GOVX 30.04%

GOVXW 49.24%

GPCR -4.15%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 4.76%

GRTX 40.48%

GTHX -10.48%

GUTS 5.77%

GXGXW 41.67%

GYRE -3.28%

HALO 0.99%

HARP 0.09%

HCWB 10.69%

HEPA 5.42%

HGEN -84.62%

HILS 5.66%

HLVX 2.75%

HOOK -1.07%

HOTH 0.67%

HOWL -9.38%

HRMY -0.10%

HRTX -1.55%

HSTO 0.00%

HUMA -1.35%

HUMAW 5.19%

IBRX 1.10%

ICCC -0.22%

ICPT 0.21%

ICU 10.12%

ICUCW 14.68%

ICVX -0.91%

IDRA -23.04%

IDYA 0.03%

IFRX 8.44%

IGMS 0.00%

IKNA -2.33%

IKT -5.00%

IMAB 2.38%

IMCR -0.28%

IMGN 0.02%

IMGO 0.00%

IMMP -2.92%

IMMX 11.76%

IMNM -4.02%

IMNN -4.46%

IMPL -27.27%

IMRA 15.96%

IMRN 12.11%

IMRX 4.20%

IMTX -1.37%

IMTXW -14.50%

IMUX -0.90%

IMV 0.00%

IMVT 0.18%

INAB -0.84%

INBX 2.18%

INCY 0.84%

INDP -1.33%

INFI -52.38%

INKT -1.62%

INM 9.72%

INMB 1.62%

INO -1.61%

INSM 0.65%

INTS 4.74%

INVA 0.63%

INZY 0.67%

IOBT 0.00%

IONS 6.81%

IOVA 1.87%

IPA -1.92%

IPHA -5.16%

IPSC -6.29%

IRON 1.81%

ISEE 0.38%

ITOS 0.61%

ITRM -5.65%

IVA -0.71%

IVVD 2.42%

JAGX -3.32%

JANX 5.52%

JAZZ 1.72%

JNCE 0.00%

JSPR 1.72%

JSPRW 4.71%

JUNS 0.00%

JUNSW 0.00%

KA 13.13%

KALV -0.17%

KDNY 0.22%

KMPH -0.34%

KNSA 1.40%

KNTE -0.38%

KOD 3.41%

KPRX 9.68%

KPTI 12.76%

KRBP -0.40%

KRON -6.48%

KROS 0.09%

KRRO -0.76%

KRTX 0.03%

KRYS 1.97%

KTRA 6.15%

KTTA 4.85%

KTTAW -5.17%

KURA 0.67%

KYMR -1.69%

KYTX 2.07%

KZIA -15.51%

KZR 1.12%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.13%

LENZ -1.52%

LEXX -1.49%

LEXXW -0.19%

LGND 0.72%

LGNDV 0.00%

LGVN -12.73%

LIAN -8.28%

LIFE 2.70%

LIPO 10.88%

LIXT -1.57%

LIXTW 0.00%

LJPC -0.32%

LMNL 0.12%

LOGC 1.27%

LPCN 3.56%

LPTX -2.08%

LQDA 3.28%

LRMR -10.33%

LSTA -3.26%

LTRN -5.78%

LUMO 1.79%

LVTX 0.27%

LXEO 4.94%

LXRX -2.16%

LYEL 3.41%

LYRA -2.78%

MACK 0.10%

MBIO 2.70%

MBRX -3.48%

MCRB -2.19%

MDGL 2.00%

MDNA -13.16%

MDWD 7.88%

MDXG -1.02%

MEIP -2.80%

MESO -3.28%

MGNX 2.97%

MGTA -7.74%

MGTX -3.18%

MGX 0.56%

MIRM 8.74%

MIRO 0.59%

MIST 0.72%

MITO 0.00%

MLEC -5.36%

MLECW 90.24%

MLND -5.36%

MLTX 0.73%

MLYS 4.90%

MNKD 6.26%

MNMD 0.27%

MNOV 0.00%

MNPR 15.76%

MOLN -25.10%

MOR -0.11%

MORF 10.26%

MREO -5.53%

MRKR 9.03%

MRNA 2.70%

MRNS 3.01%

MRSN 3.76%

MRTX -0.17%

MRUS 3.77%

MRVI -2.35%

MTCR -1.29%

MTEM -4.59%

MTP -18.50%

MURA -0.62%

MYMD -4.12%

NAMS 8.93%

NAMSW 26.87%

NAUT -8.57%

NBRV 0.71%

NBSE -1.56%

NBTX 4.81%

NCNA -0.34%

NERV -5.52%

NEXI -2.44%

NGM -1.28%

NGNE 2.39%

NKGN 0.00%

NKGNW 8.00%

NKTR 0.86%

NKTX 1.82%

NLSP -5.16%

NLSPW 28.30%

NMRA 0.00%

NMTR -42.97%

NOVN -24.84%

NRBO 0.49%

NRIX -1.27%

NRSN -3.99%

NRSNW 0.00%

NRXP 0.75%

NRXPW 0.00%

NRXS -0.78%

NTBL 0.36%

NTEC -12.45%

NTHI 0.00%

NTLA 3.22%

NTRBW 0.00%

NUVL 1.72%

NVAX 0.14%

NVCT 2.13%

NVIV -34.28%

NXTC 3.70%

NYMX -0.05%

OABI 1.75%

OABIW -3.65%

OBIO 9.02%

OBSV 0.00%

OCEA 7.75%

OCGN -5.26%

OCS 1.37%

OCUL 4.48%

OCUP 1.27%

ODT -4.27%

OKYO -1.63%

OLMA 2.15%

OMER 2.90%

OMGA -0.41%

ONCO -6.85%

ONCR -3.08%

ONCS 31.87%

ONCT -1.85%

ONCY 0.00%

ONTX -0.47%

ONVO -2.28%

OPNT 0.00%

OPT -4.93%

ORGS -3.25%

ORIC -1.11%

ORMP -3.04%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.62%

OVID 1.28%

OYST 0.00%

PALI -3.95%

PASG 0.00%

PBLA -4.76%

PBM -4.74%

PBYI -2.34%

PCSA 0.51%

PCVX 1.12%

PDSB 8.33%

PEPG 4.57%

PGEN 4.55%

PHAR 13.76%

PHAS 0.00%

PHAT -2.26%

PHIO 3.65%

PHIOW 36.47%

PHVS -4.62%

PHXM -5.20%

PIRS -5.56%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 3.28%

PLUR -0.44%

PMN -0.63%

PMVP 4.64%

PNT 0.16%

PPBT 5.78%

PRAX -2.61%

PRDS 0.93%

PRLD 2.88%

PROG -3.47%

PROK -7.60%

PRQR -3.51%

PRTA 0.56%

PRTC -6.90%

PRTG -0.04%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -11.11%

PSTX -1.08%

PTCT -2.05%

PTE -0.82%

PTGX -0.78%

PTIXW -5.10%

PULM -2.53%

PXMD 0.00%

PYPD -1.97%

PYXS -5.34%

QLGN -8.10%

QNCX 0.71%

QNRX 1.44%

QSI 0.84%

QSIAW 1.20%

QTTB -0.71%

QURE -1.09%

RAIN -1.63%

RANI -0.96%

RAPT 3.18%

RARE -0.45%

RCKT 7.03%

REGN 1.02%

RENB 1.27%

REPL 3.06%

RETA 0.02%

REUN -0.89%

REVB 13.74%

REVBU 3.46%

REVBW 50.29%

RGLS -18.33%

RGNX 6.41%

RIGL 0.65%

RLAY -0.58%

RLMD -0.99%

RLYB 5.48%

RNA 1.69%

RNAC 1.05%

RNAZ 5.27%

RNXT 4.09%

ROIV 2.06%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.74%

RPTX 0.28%

RUBY 2.70%

RVLP -32.05%

RVMD 0.76%

RVMDW 17.51%

RVNC -3.38%

RVPH 2.40%

RVPHW 1.92%

RXDX 0.09%

RXRX 5.54%

RYTM 1.58%

RYZB 0.02%

RZLT 7.85%

SABS 4.23%

SABSW -35.81%

SAGE 3.86%

SANA 0.54%

SAVA -1.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -6.67%

SCPH 1.24%

SCPS 0.00%

SEEL -2.49%

SEER 1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 5.62%

SGMT 6.87%

SGTX -2.56%

SIOX 22.63%

SLDB 2.48%

SLGL 0.59%

SLN 3.61%

SLNO -2.60%

SLRX -3.97%

SLS -0.82%

SMMT 0.88%

SNDX -1.25%

SNGX -2.31%

SNPX 5.67%

SONN -6.53%

SPPI -0.49%

SPRB 5.39%

SPRC -2.42%

SPRO -2.92%

SRNE 15.79%

SRPT 1.95%

SRRA 0.00%

SRRK -0.47%

SRZN 5.26%

STAB 0.00%

STOK 0.70%

STRO -4.95%

STSA 0.00%

STTK -9.50%

SURF -0.93%

SVRA -5.67%

SWTX -0.17%

SYBX 2.01%

SYRS 4.12%

TALS -0.73%

TARA -1.33%

TARS 1.36%

TBPH 0.23%

TCBP -8.11%

TCDA 0.00%

TCON -1.60%

TCRR 0.00%

TCRT -3.84%

TCRX 2.92%

TECH 1.13%

TENX 9.03%

TERN 4.01%

TFFP 9.20%

TGTX 4.31%

THRX 0.12%

TIL -3.68%

TLC 0.00%

TLSA 14.49%

TNGX 0.50%

TNXP -8.46%

TNYA -0.96%

TPST 2.96%

TRDA -4.11%

TRVI -2.22%

TRVN -13.99%

TSHA -10.14%

TSVT 3.76%

TTNP -14.84%

TVTX 6.57%

TYRA 0.35%

UBX 0.36%

UNCY 7.44%

URGN 5.81%

UTHR 0.92%

VACC 11.36%

VALN 12.99%

VAXX -10.53%

VBIV 3.44%

VBLT -8.77%

VCEL 2.64%

VCNX -0.49%

VCYT 1.77%

VERA -2.79%

VERU 9.04%

VERV -0.19%

VIGL 0.52%

VINC -1.38%

VIR 0.22%

VIRI -1.85%

VIRX -5.63%

VKTX -1.18%

VLON -13.04%

VNDA -2.29%

VOR 4.20%

VRCA -4.56%

VRDN 5.09%

VRNA 4.60%

VRPX -4.95%

VRTX 1.33%

VSTM -1.90%

VTGN -3.58%

VTVT 0.00%

VTYX -0.80%

VXRT 5.82%

VYGR -0.43%

VYNE -4.95%

VYNT 7.78%

WINT 7.90%

WVE -0.76%

XBIO -5.83%

XBIT -12.02%

XCUR -3.35%

XENE -0.21%

XERS 0.00%

XFOR 0.00%

XLO 2.47%

XLRN 0.00%

XNCR 1.46%

XOMA 5.64%

XOMAO -0.20%

XOMAP -0.76%

XRTX -2.38%

YMAB 0.83%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.97%

ZNTL -3.16%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-06-21	Barbier Ann	Buy	40 000	Stock Option (right to buy)
2023-06-21	Geraghty James A	Buy	45 000	Stock Option (right to buy)
2023-06-21	Kiener Peter A	Buy	40 000	Stock Option (right to buy)
2023-06-21	Kiritsy Christopher P	Buy	40 000	Stock Option (right to buy)
2023-06-21	Richman Michael	Buy	40 000	Stock Option (right to buy)

INSIDER POWER
13.84
Last 97 transactions
Buy: 6 636 987 \| Sell: 4 508 050

Korelacja (AI algo v.1.1b): Overvalued: -0.03% $8.59 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Pieris Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
LGMK	0.857
FNWB	0.841
CUBA	0.837
NCNA	0.803
NTCT	0.801

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pieris Pharmaceuticals Finanse

Annual	2023
Przychody:	$42.81M
Zysk brutto:	$41.03M (95.84 %)
EPS:	$-21.80

FY	2023
Przychody:	$42.81M
Zysk brutto:	$41.03M (95.84 %)
EPS:	$-21.80

FY	2022
Przychody:	$25.90M
Zysk brutto:	$23.12M (89.27 %)
EPS:	$-0.420

FY	2021
Przychody:	$31.42M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.675

Financial Reports:

No articles found.

Pieris Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pieris Pharmaceuticals

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; and immune-oncology program comprises Cinrebafusp alfa, a 4-1BB/ HER2 bispecific for the treatment of HER2-high and HER2-low expressing gastric cancers. The company also develops PRS-344/S095012, a bispecific anticalin-antibody fusion protein targeting 4- 1BB and PD-L1 for immuno-oncology diseases that is in phase 1 clinical trial; and PRS-352, a preclinical-stage program addressing undisclosed targets for immuno-oncology diseases. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich, Enumeral Biomedical Holdings, Inc., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. The company also has a clinical trial collaboration and supply agreement with Eli Lilly and Company. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.